Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
Clinical trial NCT05844813 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05844813
- Sponsor
- Peking University International Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2025-11-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.